Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
SG&A Expense Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

Percentile
P0
Near historical low
vs 5Y Ago
-17.6x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-55.22%
2024119.26%
202321.89%
202246.59%
202127.09%
20203.13%
20193.59%
201816.56%
2017-12.00%
201638.40%